Health; require long-term care facilities to post a link on their websites to the official website of the office of the long-term care ombudsman
Summary
HB 906 amends Georgia law governing personal care homes, assisted living communities, and long-term care facilities. The bill expands the list of medications that may be administered in personal care homes and assisted living facilities under physician direction and protocol to include insulin, epinephrine, GLP-1 medications, and vitamin B12. In addition, it requires long-term care facilities that maintain a website to post a prominent link to the state long-term care ombudsman’s official website, along with a standardized statement explaining the ombudsman program and how residents can seek help with complaints.
The bill also establishes enforcement provisions for the website-link requirement. The Department would issue a formal warning for a first violation within 12 months, then civil monetary penalties of $100 for a second violation and $200 for third and subsequent violations in the same period. However, no penalty may be imposed if the only problem is that the link is broken, inoperable, or misdirected, and failure to maintain the link would not be grounds for revoking a license or permit. The act is set to take effect on January 1, 2027.
Impact
HB 906 would amend Code Sections 31-7-12 and 31-7-12.2 to broaden medication administration authority in personal care homes and assisted living communities, and it would revise Code Section 31-8-59 to add a new website disclosure requirement for long-term care facilities. It creates a limited penalty structure for noncompliance with the website-link mandate while preserving existing notice obligations to residents and guardians and leaving licensure intact for link-related violations. The bill affects operators of personal care homes, assisted living communities, nursing homes, and other long-term care facilities, as well as residents and families seeking ombudsman assistance.
Sentiment
The bill appears generally supportive and consumer-oriented, with no recorded opposition in the provided materials. Its stated purpose suggests a practical health-care and resident-information measure, expanding access to certain medications in care settings and improving visibility of the ombudsman complaint process. The absence of committee transcript debate or recorded votes indicates no documented controversy in the available record.
Contention
The main potential points of contention are the expanded authority for non-physician administration of medications such as insulin, epinephrine, GLP-1 drugs, and B12 in residential care settings, which may raise concerns about training, safety, and scope of practice. Another possible issue is the new website posting mandate and associated civil penalties, though the bill softens enforcement by exempting facilities from penalties when the link is merely broken or misdirected and by prohibiting license revocation for that violation. No specific opposing viewpoints are documented in the provided materials.